CDH1,CDH2,CDH3,CDH4 (C-Term) Antikörper
-
- Target
- CDH1,CDH2,CDH3,CDH4
-
Bindungsspezifität
- C-Term
- Reaktivität
- Human, Maus, Ratte
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Unkonjugiert
-
Applikation
- Western Blotting (WB), Immunohistochemistry (IHC), ELISA, Immunofluorescence (fixed cells) (IF/ICC)
- Aufreinigung
- Affinity Chromatography
- Immunogen
- Synthesized peptide derived from the C-terminal region of human E-cadherin.
- Isotyp
- IgG
-
anti-CDH1,CDH2,CDH3,CDH4 (C-Term) antibody
Reaktivität: Human WB, IHC, ELISA, IF Wirt: Kaninchen Polyclonal unconjugated
anti-CDH1,CDH2,CDH3,CDH4 antibodyReaktivität: Human WB, IHC Wirt: Kaninchen Monoclonal unconjugated
anti-CDH1,CDH2,CDH3,CDH4 (AA 800-882) antibodyReaktivität: Human WB, IP Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Aliquot and store at -20 °C or -80 °C. Avoid repeated freeze/thaw cycles.
-
-
